ArticleJournal of neuro-oncology2025

Real-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective study.

Claudia Santoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.